Top-News

Solarboom 2024: 5 Gründe die für diese Aktie sprechen…(Anzeige)

4D pharma News


Keine aktuellen Kursdaten verfügbar

WKN: A1XD45

ISIN: GB00BJL5BR07

US-Symbol: FRPRF

Typ: Aktie

Unternehmensmeldungen

08.11.18 - GlobeNewswire

4D pharma plc Announces Clinical Update for Blautix Phase II Study

First Patient Enrolment in Blautix IBS Phase II Study

24.09.18 - GlobeNewswire

4D Announces Positive Data From Phase 1b Study of Thetanix in Paediatric Crohn's Diseases Patients and Publication of Studies Showing Strong Efficacy of Thetanix in Preclinical Models of IBD

LEEDS, United Kingdom, Sept. 24, 2018 (GLOBE NEWSWIRE) -- 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics, today ...

14.08.18 - GlobeNewswire

Paper in Scientific Reports Highlights Ability of 4D Pharma’s MRx0004 to Protect Against Airway Inflammation in Severe Asthma

Data suggest that MRx0004 is a promising next-generation therapeutic for management of asthma LEEDS, United Kingdom, Aug. 14, 2018 (GLOBE NEWSWIRE) -- 4D pharma plc ...

Newssuche

Videos

08:50 Uhr

Technical Trading: AUD/USD mit Mega Chance

AUD/USD Long Typ: Turbo Open End WKN: UM0EHU Hebel: 6,42 Laufzeit: OpenEnd Einstieg: Market ... Mehr »

Solarboom 2024:

5 Gründe die für diese Aktie sprechen…
weiterlesen»

Anzeige